Literature DB >> 18665903

Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria.

E Belnoue1, S M Potter, D S Rosa, M Mauduit, A C Grüner, M Kayibanda, A J Mitchell, N H Hunt, L Rénia.   

Abstract

Previous studies have shown that IFN-gamma is essential for the pathogenesis of cerebral malaria (CM) induced by Plasmodium berghei ANKA (PbA) in mice. However, the exact role of IFN-gamma in the pathway (s) leading to CM has not yet been described. Here, we used 129P2Sv/ev mice which develop CM between 7 and 14 days post-infection with PbA. In this strain, both CD4(+) and CD8(+) T cells were involved in the effector phase of CM. When 129P2Sv/ev mice deficient in the IFN-gamma receptor alpha chain (IFN-gammaR1) were infected with PbA, CM did not occur. Migration of leucocytes to the brain at the time of CM was observed in wild type (WT) but not in deficient mice. However, in the latter, there was an accumulation of T cells in the lungs. Analysis of chemokines and their receptors in WT and in deficient mice revealed a complex, organ-specific pattern of expression. Up-regulation of RANTES/CCL5, IP-10/CCL3 and CCR2 was associated with leucocyte migration to the brain and increased expression of MCP-1/CCL2, IP-10/CCL3 and CCR5 with leucocyte migration to the lung. This shows that IFN-gamma controls trafficking of pathogenic T cells in the brain, thus providing an explanation for the organ-specific pathology induced by PbA infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18665903     DOI: 10.1111/j.1365-3024.2008.01053.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  64 in total

1.  IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria.

Authors:  Jintao Guo; James A McQuillan; Belinda Yau; Gregory S Tullo; Carole A Long; Patrick Bertolino; Ben Roediger; Wolfgang Weninger; Gregory A Taylor; Nicholas H Hunt; Helen J Ball; Andrew J Mitchell
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

2.  A role for the histone H2A deubiquitinase MYSM1 in maintenance of CD8+ T cells.

Authors:  Michael Förster; Rupinder K Boora; Jessica C Petrov; Nassima Fodil; Isabella Albanese; Jamie Kim; Philippe Gros; Anastasia Nijnik
Journal:  Immunology       Date:  2017-02-20       Impact factor: 7.397

3.  Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism.

Authors:  Judith Alferink; Sabine Specht; Hannah Arends; Beatrix Schumak; Kim Schmidt; Christina Ruland; Ramona Lundt; Andrea Kemter; Andrea Dlugos; Janina M Kuepper; Karola Poppensieker; Matthias Findeiss; Önder Albayram; David-M Otte; Janine Marazzi; Jürg Gertsch; Irmgard Förster; Wolfgang Maier; Stefanie Scheu; Achim Hoerauf; Andreas Zimmer
Journal:  J Biol Chem       Date:  2016-07-29       Impact factor: 5.157

4.  Defibrotide: a Swiss Army knife intervention in the battle against cerebral malaria.

Authors:  Julie M Moore; John W Avery
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03       Impact factor: 8.311

5.  Caspase-1 activation of interleukin-1β (IL-1β) and IL-18 is dispensable for induction of experimental cerebral malaria.

Authors:  Maximilian Kordes; Kai Matuschewski; Julius Clemence R Hafalla
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

6.  Platelets present antigen in the context of MHC class I.

Authors:  Lesley M Chapman; Angela A Aggrey; David J Field; Kalyan Srivastava; Sara Ture; Katsuyuki Yui; David J Topham; William M Baldwin; Craig N Morrell
Journal:  J Immunol       Date:  2012-06-15       Impact factor: 5.422

Review 7.  Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.

Authors:  Sabrina Torre; David Langlais; Philippe Gros
Journal:  Mamm Genome       Date:  2018-06-19       Impact factor: 2.957

8.  Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria.

Authors:  Erik W Settles; Lindsey A Moser; Tajie H Harris; Laura J Knoll
Journal:  Infect Immun       Date:  2014-01-06       Impact factor: 3.441

9.  Adjuvant activity of naturally occurring monophosphoryl lipopolysaccharide preparations from mucosa-associated bacteria.

Authors:  Paula M Chilton; Diana M Hadel; Thao T To; Thomas C Mitchell; Richard P Darveau
Journal:  Infect Immun       Date:  2013-06-24       Impact factor: 3.441

10.  Vitamin D inhibits the occurrence of experimental cerebral malaria in mice by suppressing the host inflammatory response.

Authors:  Xiyue He; Juan Yan; Xiaotong Zhu; Qinghui Wang; Wei Pang; Zanmei Qi; Meilian Wang; Enjie Luo; Daniel M Parker; Margherita T Cantorna; Liwang Cui; Yaming Cao
Journal:  J Immunol       Date:  2014-06-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.